INJ. ADRIADOX 50 MG
Product Description
RMPL Pharma LLP
-
IN
-
2018On CPHI since
-
1 - 24Employees
Company types
Categories
Specifications
RMPL Pharma LLP
-
IN
-
2018On CPHI since
-
1 - 24Employees
Company types
More Products from RMPL Pharma LLP (99)
-
Product INJ. DE-SOTAX 20 MG
USE IN -- DOCETAXEL IS A CHEMOTHERAPY DRUG. IT IS USED TO TREAT MANY TYPES OF CANCER INCLUDING BREAST , PROSTATE , STOMACH , HEAD AND NECK, AND NON -SMALL CELL LUNG CANCER . -
Product INJ. CANTECAN 100 MG
USE IN -- CHEMOTHERAPY DRUG USED TO TREAT COLO CANCER . IT MAY ALSO USED TO TREAT CANCERS
- COLORECTAL CANCER
- SYNONYMS COLON CANCER , RECTAL CANCER , BOWEL CANCER. -
Product INJ. CANTECAN 40 MG
USE IN -- CHEMOTHERAPY DRUG USED TO TREAT COLO CANCER . IT MAY ALSO USED TO TREAT CANCERS
- COLORECTAL CANCER
- SYNONYMS COLON CANCER , RECTAL CANCER , BOWEL CANCER. -
Product INJ. CARBOPIN 450 MG
USE IN -- INTITIAL TRATMENT OF ADVANCED OVARIAN CARCINOMA
- SECONDARY TRATMENT OF ADVANCED OVARIAN CARCINOMA -
Product INJ. CARBOPIN 150 MG
USE IN -- INTITIAL TRATMENT OF ADVANCED OVARIAN CARCINOMA
- SECONDARY TRATMENT OF ADVANCED OVARIAN CARCINOMA -
Product INJ. ADRIADOX 10 MG
USED IN -1. CARCINOMA OF THE CERVIX , TESTIS , BREST , OVARY AND LUNG. 2.ACUTE LYMPHATIC LEUKOMIA AND ACUTE MYELOID LEUKEMIA
3.HODGKING'S AND NON -HODGKING-S LYMPHOMA
&n... -
Product INJ. CANZATAX 100 MG
WEEKLY ADMINISTRATION OF PACLITAXEL IS HIGHLY ACTIVE AND WELL TOLERATED IN BREST CARCINOMA :-
USE IN - BREAST CARCINOMA
CERVICAL CARCINOMA
LUNG CARCINOMA ... -
Product INJ. CANZATAX 260 MG
WEEKLY ADMINISTRATION OF PACLITAXEL IS HIGHLY ACTIVE AND WELL TOLERATED IN BREST CARCINOMA
USE IN - BREAST CARCINOMA CERVICAL CARCINOMA
LUNG CARCINOMA ... -
Product INJ. CANZATAX 300 MG
WEEKLY ADMINISTRATION OF PACLITAXEL IS HIGHLY ACTIVE AND WELL TOLERATED IN BREST CARCINOMA
USE IN - BREAST CARCINOMA CERVICAL CARCINOMA
LUNG CARCINOMA &n... -
Product INJ. ARACYT 100 MG
. FOR REMISSION INDUCTION IN ACUTE NON LYMPHOCYCTIC LEUKEMIA OF BOTH ADULT AND CHILDREN..ACUTE MYELOCYTIC LEUKEMIA
.BLAST PHASE OF CHRONIC MYELOCYTIC LEUKEMIA
. NON HODGKING'S LYMPHOMA IN ADULT AND CHILDREAN
. INTHRATHECAL ADMINISTRATION OF CYTARABINE INJECTION IS INDICATED IN THE PROPHYLAXIS AND ... -
Product INJ. ARACYT 1000 MG
FOR REMISSION INDUCTION IN ACUTE NON LYMPHOCYCTIC LEUKEMIA OF BOTH ADULT AND CHILDREN..ACUTE MYELOCYTIC LEUKEMIA
.BLAST PHASE OF CHRONIC MYELOCYTIC LEUKEMIA
. NON HODGKING'S LYMPHOMA IN ADULT AND CHILDREAN
. INTHRATHECAL ADMINISTRATION OF CYTARABINE INJECTION IS INDICATED IN THE PROPHY... -
Product INJ. ARACYT 500 MG
FOR REMISSION INDUCTION IN ACUTE NON LYMPHOCYCTIC LEUKEMIA OF BOTH ADULT AND CHILDREN..ACUTE MYELOCYTIC LEUKEMIA
.BLAST PHASE OF CHRONIC MYELOCYTIC LEUKEMIA
. NON HODGKING'S LYMPHOMA IN ADULT AND CHILDREAN
. INTHRATHECAL ADMINISTRATION OF CYTARABINE INJECTION IS INDICATED IN THE PROPHY...
RMPL Pharma LLP resources (1)
-
Brochure RMPL PHARMA LLP.
The primary goal of RMPL PHARMA LLP. is to supply our consumers with pharmaceutical products by providing assurance regarding their performance safety, value and consistency. The commitment to quality is well rooted in corporate values of our company and is very essential to our continuous development & success.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance